KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Benjamin L Palleiko sold $86K of KalVista Pharmaceuticals, Inc.
Sold$86,068
$11.53Price
7,465Shares
−3%Stake
What KALV did after the filing
- The stock from Tue, Jun 11 open, $11.90
- +20.9%
- S&P 500, same days
- +1.1%
Measured over 30 trading days, to the Jul 25 close.
Traded Fri, Jun 7. Filed Mon, Jun 10, 6:42 PM ET, after the close. Returns use the Jun 11 open and the Jul 25 close. Not investment advice.